Bradsaúde’s Atlântica to Take 49.9% Stake in Oncology Venture With Fleury

• Bradsaúde disclosed a memorandum of understanding for its indirectly controlled Atlântica to invest in Fleury’s outpatient oncology business.
• Fleury will own 50.1% of the new company; Atlântica will hold 49.9%.
• Initial investment totals R$ 72 million through 2027, funded proportionally to the partners’ ownership stakes.
• Fleury will contribute existing oncology assets; Atlântica’s cash contribution will reflect asset values and pre-operating costs, with those costs adjusted by CDI.
• Completion requires regulatory approvals and definitive investment and shareholder agreements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bradsaude SA published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.